Studying the Relationship Between Contact Lens Packaging Solutions and Bacterial Binding to Surface Eye Cells
Study Details
Study Description
Brief Summary
The goal of this study is to investigate the overall theory that the use of chemically preserved solutions associated with contact lenses promotes an increase in bacterial infection.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The purpose of this study is to investigate the theory of bacterial binding to surface eye cells through the use of chemically preserved solutions.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Contact Lens Packaging Solution #1 Test solution - contact lens packaging solution |
Device: Contact lens packaging solution
These test solutions are the intervention being tested.
Other Names:
|
Experimental: Contact lens packaging solution #2 Test solution - contact lens packaging solution |
Device: Contact lens packaging solution
These test solutions are the intervention being tested.
Other Names:
|
Placebo Comparator: Balanced salt solution Control solution |
Device: Balanced salt solution (BSS)
BSS is isotonic to the tissues of the eyes.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Bacterial binding of Pseudomonas Aeruginosa [5 weeks]
Counting the number of bacteria that bind to surface epithelial cells.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age range: 18-38 years
-
Any sex, race or national origin accepted as with our past studies. Minority representation will be proactively encouraged.
-
No prior history of any contact lens wear within one month of entry into the study.
-
No history of allergic eye disease either seasonal or associated with previous contact lens wear.
Exclusion Criteria:
-
Any patient that is a current contact lens wearer.
-
Patients with active ocular infection or inflammatory disease, history of herpetic keratitis, glaucoma, etc.
-
Uncontrolled systemic disease or the presence of any significant illness or condition that could, in the judgment of the investigator, interfere with interpretation of the study results.
-
Any patient using ocular tears, anti-histamine based ocular therapies, glaucoma therapy, vasoconstricting drops, etc.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | UT Southwestern Medical Center | Dallas | Texas | United States | 75390 |
Sponsors and Collaborators
- University of Texas Southwestern Medical Center
Investigators
- Principal Investigator: Danielle Robertson, OD, PhD, UT Southwestern Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 032010-081